1. 104 ADAPTATIONS IN EXCITATION-CONTRACTION COUPLING IN CARDIAC-SPECIFIC NA+/CA2+ EXCHANGER KNOCKOUT MICE. (1st January 2005) Authors: Pott, C.; Philipson, K. D.; Goldhaber, J. I. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 255 INCREASED TRANSIENT OUTWARD CURRENT, SHORTENED ACTION POTENTIAL DURATION AND "SHORT-QT SYNDROME" IN NA+/CA2+ EXCHANGER KNOCKOUT MICE. (1st January 2006) Authors: Pott, C.; Ren, X.; Jordan, M. C.; Roos, K. P.; Philipson, K. D.; Goldhaber, J. I. Journal: Journal of investigative medicine Issue: Volume 54:Number 1(2006) Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 390 DEPENDENCY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE-ACTIVATION MECHANISMS ON INTRACELLULAR CA2+-CONCENTRATION IN HUMAN ATRIAL MYOCARDIUM. (1st January 2005) Authors: Pott, C.; Bloch, W.; Steinritz, D.; Brixius, K.; Mehlhorn, U.; Ziskoven, C.; Schwinger, R. H.G. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A SINGLE‐CELL BASED MODEL EXPLAINS PATTERNS OF CLONAL EVOLUTION IN PRIMARY AND RELAPSED FOLLICULAR LYMPHOMA. (June 2017) Authors: Loeffler, M.; Horn, M.; Kreuz, M.; Siebert, R.; Pott, C.; Trautmann, H.; Klapper, W.; Küppers, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY. (12th June 2019) Authors: Launonen, A.; Casulo, C.; Pott, C.; Rusconi, C.; Hernandez, J.; Davies, A.J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. COMBINATION IBRUTINIB (IBR) AND VENETOCLAX (VEN) FOR THE TREATMENT OF MANTLE CELL LYMPHOMA (MCL): PRIMARY ENDPOINT ASSESSMENT OF THE PHASE 2 AIM STUDY. (June 2017) Authors: Tam, C.S.; Roberts, A.W.; Anderson, M.; Dawson, S.; Hicks, R.; Burbury, K.; Turner, G.; Di Iulio, J.; Bressel, M.; Westerman, D.; Agarwal, R.; Pott, C.; Dreyling, M.; Dawson, M.; Seymour, J.F. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MCL‐R2 ELDERLY: A PHASE III STUDY OF THE EUROPEAN MCL NETWORK ASSESSING EFFICACY OF ALTERNATING IMMUNOCHEMOTHERAPY (R‐CHOP / R‐HAD) AND a RITUXIMAB‐LENALIDOMIDE MAINTENANCE. (June 2017) Authors: Ribrag, V.; Feugier, P.; Doorduijn, J.; Delfau‐Larue, M.; Hermine, O.; Kluin‐Nelemans, H.; Dasilva, M.; Lopez‐Hernandez, A.; Walewski, J.; Szymczyk, M.; Pott, C.; Homburg, C.; Van der Velden, V.; Gameiro, P.; Garcia‐Sanz, R.; Ladetto, M.; van Krieken, H.; Cabeçadas, J.; Rymkiewicz, G.; Klapper, W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MINIMAL RESIDUAL DISEASE AND OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) IN THE PHASE III GADOLIN TRIAL OF OBINUTUZUMAB AND BENDAMUSTINE VS BENDAMUSTINE. (June 2017) Authors: Pott, C.; Belada, D.; Danesi, N.; Fingerle‐Rowson, G.R.; Gribben, J.; Harbron, C.G.; Hoster, E.; Kahl, B.S.; Kehden, B.; Mundt, K.E.; Nicolas‐Virelizier, E.; Sehn, L.H.; Cheson, B.D. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PREDICTION OF RELAPSE BY STANDARDIZED IG‐BASED ALLEL‐SPECIFIC QPCR, DDPCR AND AMPLICON NGS FOR MRD MONITORING IN MANTLE CELL LYMPHOMA: A COMPARATIVE ANALYSIS BY THE EU‐MCL NETWORK. (17th June 2021) Authors: Pott, C.; Macintyre, E.; Delfau, M.‐H.; Weiß, A.; Schilhabel, A.; Soehlbrand, A.; Kehden, B.; Darzentas, N.; Kotrova, M.; Schoen, F.; Ribrag, V.; Brueggemann, M.; Villarese, P.; Dreyling, M.; Hermine, O.; Kluin‐Nelemans, H.; Jiang, L.; Hoster, E. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAKK 35/15: A PHASE I TRIAL OF OBINUTUZUMAB IN COMBINATION WITH VENETOCLAX IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019) Authors: Stathis, A.; Mey, U.; Schär, S.; Hitz, F.; Pott, C.; Mach, N.; Krasniqi, F.; Novak, U.; Schmidt, C.; Hohloch, K.; Kienle, D.; Hess, D.; Moccia, A.; Unterhalt, M.; Eckhardt, K.; Hayoz, S.; Rossi, D.; Dirnhofer, S.; Ceriani, L.; Bertoni, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗